Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Int J Audiol. 2017 Oct 3;57(SUP2):S41–S54. doi: 10.1080/14992027.2017.1380851

Table 4.

Demographic characteristics of participants in the randomised prescription trial. Independent Samples t tests were used to compare the cognitive ability (WNV) scores and age at hearing aid fitting between the two prescription groups. Chi-square tests were used to compare the percentage differences between the two prescription groups on gender, presence of additional disabilities, and degree of hearing loss.

Characteristics NAL group
(n=89)
DSL group
(n=74)
Difference
p value
Gender (Male)
 No. (percentage) 57 (64.0%) 40 (54.1%) 0.64
Presence of additional disabilities (AD)
 No. (percentage) 30 (33.7%) 22 (29.7%) 0.99
Age at hearing aid fitting (months)
 Mean (SD) 11.2 (10.7) 10.0 (10.5)
 Median 6.0 4.0 0.49
 Interquartile range 3.0–17.0 2.0–18.8
Degree of Hearing Loss* (4FA HL in better ear)
 No. (percentage):Mild (≤ 40 dB): 20 (22.5%) 23 (31.1%)
 No. (percentage): Moderate (41–60 dB) 51 (57.3%) 36 (48.6%) 0.43
 No. (percentage): Severe (61–80 dB) 18 (20.2%) 15 (20.3%)
Cognitive ability (WNV)@
 N 76 63
 Mean (SD) 100.9(17.2) 104.1(16.0) 0.24
 Median 100.0 105.0
 Interquartile range (IQR) 91.0–116.0 95.5–116.5

Note:

*

4FA HL= Four frequency average hearing loss (average of hearing threshold levels at 0.5, 1, 2, and 4 kHz).

@

WNV = Wechsler Non-Verbal Full Scale IQ. Due to missing data, scores are based on the numbers of participants as specified.